Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
February 13, 2024 08:00 ET
|
Nano-X Imaging LTD.
Nanox’s HealthFLD is pioneering the use of a fully automated AI software for liver attenuation analysis from CT scans that has received FDA 510(k) clearance for use in general population Expands...
Nanox Mourns Death of Its Founder, Ran Poliakine
January 16, 2024 08:30 ET
|
Nano-X Imaging LTD.
Nanox Mourns Death of Its Founder, Ran Poliakine
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
November 28, 2023 08:05 ET
|
Nano-X Imaging LTD.
Reports progress towards global supply chain development and commercial deployment Ended the third quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $95.6...
Nanox to Report Third Quarter 2023 Financial Results on November 28, 2023 and Reschedules Investor Day for December 4, 2023
November 09, 2023 09:00 ET
|
Nano-X Imaging LTD.
NEVE ILAN, Israel, Nov. 09, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will...
Nanox Continues Business as Planned, and Postpones Investor Day Scheduled for October 17, 2023
October 10, 2023 09:22 ET
|
Nano-X Imaging LTD.
Nanox to Postpone Investor Day Originally Scheduled for October 17, 2023
Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
October 03, 2023 08:30 ET
|
Nano-X Imaging LTD.
NEVE ILAN, Israel and SALT LAKE CITY, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company today announced...
Nanox to Host Investor Day on October 17, 2023
October 02, 2023 09:00 ET
|
Nano-X Imaging LTD.
Nanox to Host Investor Day on October 17, 2023
Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs
September 28, 2023 08:30 ET
|
Nano-X Imaging LTD.
Beilinson Hospital in Israel used Nanox.AI’s HealthCCSng solution to conduct study on routine chest CT scans to assess impact of AI-based coronary artery calcium (CAC) measurements Nanox.AI’s...
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
September 13, 2023 08:30 ET
|
Nano-X Imaging LTD.
NEVE ILAN, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced its...
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
August 17, 2023 08:00 ET
|
Nano-X Imaging LTD.
Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $80.3 million Management to host...